Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ALCON RESEARCH
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses
Not Applicable
Completed
Conditions
Presbyopia
Interventions
Device: Lotrafilcon B MF
Device: Lotrafilcon B MV
Device: Lotrafilcon B SVD
Device: Comfilcon A MF
Device: Habitual contact lenses
Subscribe
First Posted Date
2014-07-15
Last Posted Date
2016-02-18
Lead Sponsor
Alcon Research
Target Recruit Count
33
Registration Number
NCT02189863
Subscribe
Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses
Not Applicable
Completed
Conditions
Presbyopia
Corneal Astigmatism
Cataract
Interventions
Device: AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL
Subscribe
First Posted Date
2014-06-27
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
37
Registration Number
NCT02176343
Subscribe
A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Phemfilcon A contact lenses with color printing
Device: Lotrafilcon B contact lenses with color printing
Subscribe
First Posted Date
2014-06-26
Last Posted Date
2015-10-14
Lead Sponsor
Alcon Research
Target Recruit Count
151
Registration Number
NCT02175199
Subscribe
DW Evaluation of Lotrafilcon B Lenses in a Modified Design
Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Lotrafilcon B sphere contact lenses
Device: Lotrafilcon B sphere modified design contact lenses
Subscribe
First Posted Date
2014-06-06
Last Posted Date
2015-08-11
Lead Sponsor
Alcon Research
Target Recruit Count
134
Registration Number
NCT02157909
Subscribe
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
Conditions
Ocular Hypertension
Glaucoma
Interventions
Drug: Travoprost 0.004% ophthalmic solution TRAVATAN Z®
Drug: Dose Level B / Brinzolamide 1% ophthalmic suspension
Drug: Brinzolamide 1% ophthalmic suspension AZOPT®
Drug: Dose Level A / Brinzolamide 1% ophthalmic suspension
Drug: Dose Level C / Brinzolamide 1% ophthalmic suspension
Drug: Brinzolamide suspension vehicle
Drug: Travoprost solution vehicle
Subscribe
First Posted Date
2014-05-16
Last Posted Date
2015-12-29
Lead Sponsor
Alcon Research
Target Recruit Count
327
Registration Number
NCT02140060
Subscribe
Multifocal High ADD Contact Lens Proof of Concept Trial
Not Applicable
Completed
Conditions
Presbyopia
Interventions
Device: Lotrafilcon B multifocal contact lenses (new)
Device: Lotrafilcon B multifocal contact lenses
Subscribe
First Posted Date
2014-04-21
Last Posted Date
2015-08-26
Lead Sponsor
Alcon Research
Target Recruit Count
268
Registration Number
NCT02117544
Subscribe
Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan
Not Applicable
Completed
Conditions
Myopia
Myopic Astigmatism
Refractive Error
Interventions
Device: Nelfilcon A contact lenses
Device: Etafilcon A contact lenses
Subscribe
First Posted Date
2014-04-03
Last Posted Date
2014-10-29
Lead Sponsor
Alcon Research
Target Recruit Count
42
Registration Number
NCT02103309
Subscribe
On-Eye Evaluation of Contact Lens Axis Location
Not Applicable
Completed
Conditions
Refractive Error
Myopia
Astigmatism
Interventions
Device: Delefilcon A toric contact lens T1
Device: Delefilcon A toric contact lens T3
Device: Delefilcon A toric contact lens T5
Device: Delefilcon A toric contact lens T2
Device: Delefilcon A toric contact lens T4
Device: Delefilcon A toric contact lens T6
Subscribe
First Posted Date
2014-04-01
Last Posted Date
2014-05-16
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT02100410
Subscribe
Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses
Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: Nelfilcon A contact lenses
Device: Stenfilcon A contact lenses
Subscribe
First Posted Date
2014-03-17
Last Posted Date
2015-05-15
Lead Sponsor
Alcon Research
Target Recruit Count
31
Registration Number
NCT02089191
Locations
🇩🇪
Alcon Investigative Site, Jena, Germany
Subscribe
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
Phase 2
Completed
Conditions
Allergic Conjunctivitis
Interventions
Drug: AL-53817 Vehicle
Drug: AL-53817 Ophthalmic Solution, 0.1%
Drug: AL-78843 Ophthalmic Solution, 0.03%
Drug: Dexamethasone Ophthalmic Suspension, 0.1%
Subscribe
First Posted Date
2014-03-06
Last Posted Date
2015-08-24
Lead Sponsor
Alcon Research
Target Recruit Count
224
Registration Number
NCT02079649
Subscribe
Prev
1
18
19
20
21
22
61
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy